Refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation: is this phenomenon airway remodeling?

H. Tanimoto, M. Taniguchi, Y. Fukutomi, C. Oshikata, E. Ono, K. Sekiya, T. Tsuburai, N. Tsurikisawa, M. Otomo, Y. Maeda, A. Mori, M. Hasegawa, K. Akiyama (Sagamihara, Japan)

Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Session: Improving asthma therapy - new findings in established and experimental treatment modalities
Session type: Thematic Poster Session
Number: 3655
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Tanimoto, M. Taniguchi, Y. Fukutomi, C. Oshikata, E. Ono, K. Sekiya, T. Tsuburai, N. Tsurikisawa, M. Otomo, Y. Maeda, A. Mori, M. Hasegawa, K. Akiyama (Sagamihara, Japan). Refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation: is this phenomenon airway remodeling?. Eur Respir J 2007; 30: Suppl. 51, 3655

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010


Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009

Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016
Year: 2017



Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017
Year: 2017



Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007


Airway inflammation and inhaled corticosteroids in COPD
Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017
Year: 2017



The effect of inhaled budesonide and formoterol on bronchial remodeling in young asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 208s
Year: 2006

Inhaled corticosteroids and growth of airway function in asthmatic children
Source: Eur Respir J 2004; 23: 861-868
Year: 2004



Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma
Source: Eur Respir J 2006; 27: 172-187
Year: 2006



Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2-agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 35s
Year: 2003

Effects of intervention with high-dose inhaled corticosteroids on airway remodelling in diagnosed genetic variants of IL13 with asthma
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010


Dose–response for inhaled fluticasone on airway and systemic inflammation in COPD
Source: Eur Respir J 2011; 37: 206-209
Year: 2011


Dose response for inhaled fluticasone on airway and systemic inflammation in COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009

Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma
Source: Eur Respir J 2002; 20: 1080-1087
Year: 2002



Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008


Effects of inhaled corticosteroids on asthmatic inflammation: The FeNOtype trial
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012


Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 670s
Year: 2006

The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 57s
Year: 2002

Effect of formoterol with or without budesonide in repeated low-dose allergen challenge
Source: Eur Respir J 2009; 33: 747-753
Year: 2009



Changes in airway inflammation, remodelling and PD20 following inhaled corticosteroid treatment are not temporally concordant
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001